Does a patient need to have an estimated Glomerular Filtration Rate (eGFR) of less than 60 ml/min/1.73m² to be diagnosed with Chronic Kidney Disease (CKD), or can a diagnosis be made with an eGFR of 60-89 ml/min/1.73m²?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CKD Diagnosis: eGFR Thresholds and Kidney Damage Criteria

CKD can be diagnosed with an eGFR of 60-89 mL/min/1.73 m² if there is evidence of kidney damage present for at least 3 months, but eGFR <60 mL/min/1.73 m² alone is sufficient to diagnose CKD regardless of whether kidney damage markers are present. 1

Understanding the Two-Part Definition

CKD requires either of the following criteria persisting for ≥3 months: 1, 2

  • eGFR <60 mL/min/1.73 m² (with or without kidney damage markers)
  • Evidence of kidney damage (with any eGFR level, including ≥60)

When eGFR is 60-89 mL/min/1.73 m² (Stage 2 CKD)

You must have documented kidney damage to diagnose CKD at this eGFR range. 1 Acceptable markers of kidney damage include: 1, 2

  • Albuminuria: UACR ≥30 mg/g (most common marker)
  • Pathological abnormalities on kidney biopsy
  • Imaging abnormalities: structural changes, cysts, or other renal abnormalities on ultrasound/CT
  • Urine abnormalities: persistent hematuria or other abnormal findings
  • History of kidney transplantation

Without any of these damage markers, an eGFR of 60-89 mL/min/1.73 m² does not constitute CKD—it may represent normal kidney function, particularly in younger individuals. 1, 3

When eGFR is <60 mL/min/1.73 m² (Stage 3-5 CKD)

No additional markers are required. 1 An eGFR persistently <60 mL/min/1.73 m² for ≥3 months is diagnostic of CKD by itself, regardless of whether albuminuria or other damage markers are present. 2

Critical Confirmation Strategy for Borderline Cases

When creatinine-based eGFR is 45-59 mL/min/1.73 m² (Stage 3a) without other kidney damage markers, measure cystatin C to confirm true CKD. 4, 5 This is essential because:

  • Approximately 23% of patients with creatinine-based eGFR 45-59 actually have normal kidney function when confirmed with cystatin C 4
  • If cystatin C-based eGFR is ≥60 mL/min/1.73 m², CKD diagnosis is not confirmed 4
  • If cystatin C-based eGFR is <60 mL/min/1.73 m², CKD diagnosis is confirmed 4
  • The combined creatinine-cystatin C equation (eGFRcreat-cys) provides 94.9% accuracy and should guide clinical decisions 4, 5

Common Pitfall to Avoid

Do not diagnose CKD in patients with eGFR 60-89 mL/min/1.73 m² who lack evidence of kidney damage. 3 Misdiagnosing CKD has negative consequences including insurance implications, unnecessary patient anxiety, and inappropriate nephrology referrals. 3 Always verify that patients with Stage 1-2 CKD have documented albuminuria, structural abnormalities, or other damage markers before assigning the diagnosis. 1, 2

Staging Algorithm

Once CKD is confirmed, stage according to eGFR: 1

  • Stage 1: eGFR ≥90 (requires kidney damage markers)
  • Stage 2: eGFR 60-89 (requires kidney damage markers)
  • Stage 3a: eGFR 45-59 (no damage markers required)
  • Stage 3b: eGFR 30-44 (no damage markers required)
  • Stage 4: eGFR 15-29 (no damage markers required)
  • Stage 5: eGFR <15 or dialysis (no damage markers required)

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cystatin C Testing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Estimating Kidney Function using eGFR

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the stages of Chronic Kidney Disease (CKD)?
What is the classification of Chronic Kidney Disease (CKD)?
Is a patient with a history of chronic kidney disease (CKD) always in stage 3a if their Glomerular Filtration Rate (GFR) improves above 60 ml/min/1.73m^2?
What is the diagnosis and management plan for a patient with a Glomerular Filtration Rate (GFR) of 56, indicating impaired renal function?
How is Chronic Kidney Disease (CKD) staged using the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines and estimated Glomerular Filtration Rate (eGFR)?
What is the difference between halobetasol and clobetasol for treating inflammatory skin conditions?
What is the best course of treatment for a patient with a large rash on the lateral left chest wall and posterior upper left arm consistent with cellulitis, considering potential allergies and previous reactions to antibiotics, and possible history of Methicillin-resistant Staphylococcus aureus (MRSA) or other resistant organisms?
Should linagliptin (a dipeptidyl peptidase-4 (DPP-4) inhibitor) be started instead of gliclazide in a patient with type 2 diabetes and a history of severe hypoglycemic episodes or adrenal insufficiency?
What is the best course of action for a 22-year-old female with lower abdominal pain, elevated liver enzymes (aspartate aminotransferase (AST) and alanine aminotransferase (ALT) of 55), alkaline phosphatase (alk phos) of 127, and hyperbilirubinemia (total bilirubin of 2.4), with no known past medical history?
What is the correlation between hypothyroid (underactive thyroid) disorder and insulin resistance, particularly in adults with a history of thyroid issues or metabolic syndrome?
What is the best approach to manage patient-ventilator asynchrony in a critically ill intensive care unit (ICU) patient with potential respiratory muscle weakness and pre-existing respiratory or cardiac conditions?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.